Real world outcomes of enhanced monofocal intraocular lens in eyes with retinal diseases treated with phacovitrectomy

Abstract

Purpose : To assess the visual outcomes of a monofocal intraocular lens (IOL) with enhanced intermediate function (Tecnis Eyhance), compared to a conventional monofocal (Tecnis PCB00) IOL in eyes with diverse retinal diseases

Methods : This retrospective case-control study included 200 eyes of 200 patients who underwent phacovitrectomy for the treatment of retinal diseases with the Eyhance. Additionally, 100 eyes from age-matched patients who received the PCB00 were included. They were consisted of various conditions including epiretinal membrane (ERM; 70%), macular hole (MH; 8%), rhegmatogenous retinal detachment (RRD; 9%), vitreous hemorrhage (VH; 10%), and other (2%). Uncorrected distance (UDVA), intermediate (UIVA), and near (UNVA) visual acuity were assessed before and after the surgery. Similarly, corrected visual acuity (CDVA, CIVA, and CNVA) were measured.

Results : Baseline characteristics were similar between the PCB00 and Eyhance groups. The eyes with ERM showed better UIVA and CIVA with Eyhance than with PCB00 IOL at 3 and 6 months postoperatively. The RRD group which did not show a difference of intermediate vision at 3 months between two IOLs, demonstrated better UIVA and CIVA at 6 months with Eyhance. There were no differences of intermediate vision in eyes with MH and VH between IOLs.

Conclusions : The Eyhance IOL showed improved intermediate vision for the majority of patients in retinal clinic. However, its effectiveness was less pronounced in a subset of patients with MH and VH. A selective approach is recommended when considering the use of enhanced monofocal IOL in the planning of phacovitrectomy for eyes with retinal diseases.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.